Back to Trades
Sell4
MADRIGAL PHARMACEUTICALS, INC.
MDGL
Total Value
$4.5M
Net $2.4M sold
Sales
$2.4M
15 transactions
Company Information
- Company Name
- MADRIGAL PHARMACEUTICALS, INC.
- Ticker Symbol
- MDGL
- CIK
- 0001157601
Insider Information
- Name
- Dier Mardi
- Role
- EVP and CFO
- Location
- WEST CONSHOHOCKEN, PA
Officer
Filing Details
- Filing Date
- Dec 3, 2025
- Transaction Date
- Dec 2, 2025
- Accession Number
- 0001628280-25-055164
- Form Type
- 4
- Net Trading Amount
- -$2.4M
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Dec 2, 2025 | Common Stock | 4,173 | $251.63 | Exercise | $1.1M |
| Dec 2, 2025 | Common Stock | 320 | $570.39 | Sale | $182.5K |
| Dec 2, 2025 | Common Stock | 410 | $571.99 | Sale | $234.5K |
| Dec 2, 2025 | Common Stock | 354 | $573.02 | Sale | $202.8K |
| Dec 2, 2025 | Common Stock | 717 | $574.00 | Sale | $411.6K |
| Dec 2, 2025 | Common Stock | 120 | $574.95 | Sale | $69.0K |
| Dec 2, 2025 | Common Stock | 240 | $576.15 | Sale | $138.3K |
| Dec 2, 2025 | Common Stock | 320 | $577.81 | Sale | $184.9K |
| Dec 2, 2025 | Common Stock | 258 | $578.83 | Sale | $149.3K |
| Dec 2, 2025 | Common Stock | 480 | $579.85 | Sale | $278.3K |
| Dec 2, 2025 | Common Stock | 240 | $585.44 | Sale | $140.5K |
| Dec 2, 2025 | Common Stock | 240 | $587.85 | Sale | $141.1K |
| Dec 2, 2025 | Common Stock | 160 | $589.65 | Sale | $94.3K |
| Dec 2, 2025 | Common Stock | 160 | $590.37 | Sale | $94.5K |
| Dec 2, 2025 | Common Stock | 74 | $595.20 | Sale | $44.0K |
| Dec 2, 2025 | Common Stock | 80 | $596.19 | Sale | $47.7K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Dec 2, 2025 | Derivative | 4,173 | $251.63 | Exercise | $1.1M |
Footnotes
- (F1)These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 2, 2025.
- (F2)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $570.17 to $570.77, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below.
- (F3)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $571.45 to $572.34, inclusive.
- (F4)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $572.48 to $573.38, inclusive.
- (F5)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $573.59 to $574.44, inclusive.
- (F6)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $574.67 to $575.24, inclusive.
- (F7)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $575.69 to $576.46, inclusive.
- (F8)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $577.36 to $578.31, inclusive.
- (F9)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $578.37 to $579.20, inclusive.
- (F10)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $579.59 to $580.46, inclusive.
- (F11)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $585.08 to $585.99, inclusive.
- (F12)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $587.58 to $588.07, inclusive.
- (F13)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $589.13 to $589.96, inclusive.
- (F14)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $590.15 to $590.58, inclusive.
- (F15)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $595.18 to $595.41, inclusive.
- (F16)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $596.18 to $596.19, inclusive.
- (F17)All shares issued pursuant to the exercise of the options reported herein represent 4,173 shares underlying an overall option award of 13,353 shares. All exercised options had vested. As to the overall option for 13,353 shares, 25% of the shares vested on March 1, 2025, and, thereafter, 6.25% of the shares vested or will vest on the last day of each successive three-month period, provided the Reporting Person continues in service with the Issuer on each such date.